Annual Report to the Nation on the Status of Cancer Part 2 - NCI

Part 2 of the 2021 Annual Report to the Nation on the Status of Cancer, finds that the patient economic burden associated with cancer care in the United States in 2019 was $21.09 billion. This includes patient out-of-pocket costs of $16.22 billion and patient time costs of $4.87 billion.

Chronic Myeloid Leukemia: Part II—Cost of Care Among Patients in Advanced Phases or Later Lines of Therapy in Chronic Phase in the United States from a Commercial Perspective

Annual Report to the Nation Part 2 - Cancer Care Economic Burden

Cancer in 2022 AACR Cancer Progress Report 2022

Breast Cancer by State: Comparing Mortality Rates Across the U.S.

Cancer - Wiley Online Library

AACR Cancer Progress Report Details Exciting Advances in Cancer Research and Treatment - Cancer Health

Cancer Research Training and Education Coordination

Annual Report to the Nation Part 2 - Cancer Care Economic Burden

Global Cancer Statistics 2020: GLOBOCAN Estimates of Incidence and

Adjuvant Trastuzumab in HER2-Positive Breast Cancer

Cancers, Free Full-Text